Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia

BACKGROUND: Nowadays, there are two vaccination strategies in Colombia to prevent pneumococcal diseases in people over 50 years. Our aim is to estimate cost-effectiveness of pneumococcal conjugate vaccine 13-valent (PCV13) versus pneumococcal polysaccharide vaccine 23-valent (PPSV23) to prevent pneu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordóñez, Jaime E, Orozco, John J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994250/
https://www.ncbi.nlm.nih.gov/pubmed/24679135
http://dx.doi.org/10.1186/1471-2334-14-172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994250/
https://www.ncbi.nlm.nih.gov/pubmed/24679135
http://dx.doi.org/10.1186/1471-2334-14-172

Ejemplares similares